| Quad City Family Physicians, Pc | |
|
3940 N Marquette St Davenport IA 52806-4430 | |
| (563) 386-3111 | |
| Not Available |
| Full Name | Quad City Family Physicians, Pc |
|---|---|
| Speciality | General Practice |
| Location | 3940 N Marquette St, Davenport, Iowa |
| Authorized Official Name and Position | Elizabeth Estilow (OFFICE MANAGER) |
| Authorized Official Contact | 8774796525 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Quad City Family Physicians, Pc 3940 N Marquette St Davenport IA 52806-4430 Ph: (563) 386-3111 | Quad City Family Physicians, Pc 3940 N Marquette St Davenport IA 52806-4430 Ph: (563) 386-3111 |
| NPI Number | 1265430961 |
|---|---|
| Provider Enumeration Date | 07/07/2005 |
| Last Update Date | 07/21/2022 |
| Medicare PECOS PAC ID | 5193717361 |
|---|---|
| Medicare Enrollment ID | O20040330001741 |
News Archive
The study shows that L. reuteri Prodentis acts synergistically with standard treatment (scaling and root plaining, SRP) to significantly reduce probing pocket depth (PPD) and clinical attachment level (CAL) which are the two most important parameters to assess the severity of periodontitis. Furthermore L. reuteri Prodentis reveals - as the first probiotic ever - significant reductions of three different pathogens in patients with chronic periodontitis.
The smell of cut grass, freshly baked bread, childhood memories, lost loved ones. What happens when it's all gone?
A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found.
Swedish researchers report in an article published in the Journal of Alzheimer´s Disease that 46% of patients who are diagnosed with Alzheimer´s disease in Sweden live alone in their homes, in particular older women.
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265430961 | NPI | - | NPPES |
| 0293688 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | (Iowa) | Primary |
| Provider Name | Jason G Davis |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1588662050 PECOS PAC ID: 1355333527 Enrollment ID: I20100520000106 |
News Archive
The study shows that L. reuteri Prodentis acts synergistically with standard treatment (scaling and root plaining, SRP) to significantly reduce probing pocket depth (PPD) and clinical attachment level (CAL) which are the two most important parameters to assess the severity of periodontitis. Furthermore L. reuteri Prodentis reveals - as the first probiotic ever - significant reductions of three different pathogens in patients with chronic periodontitis.
The smell of cut grass, freshly baked bread, childhood memories, lost loved ones. What happens when it's all gone?
A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found.
Swedish researchers report in an article published in the Journal of Alzheimer´s Disease that 46% of patients who are diagnosed with Alzheimer´s disease in Sweden live alone in their homes, in particular older women.
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.
› Verified 2 days ago
| Provider Name | Danielle M Coberly |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841802279 PECOS PAC ID: 8820498371 Enrollment ID: I20210621001936 |
News Archive
The study shows that L. reuteri Prodentis acts synergistically with standard treatment (scaling and root plaining, SRP) to significantly reduce probing pocket depth (PPD) and clinical attachment level (CAL) which are the two most important parameters to assess the severity of periodontitis. Furthermore L. reuteri Prodentis reveals - as the first probiotic ever - significant reductions of three different pathogens in patients with chronic periodontitis.
The smell of cut grass, freshly baked bread, childhood memories, lost loved ones. What happens when it's all gone?
A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found.
Swedish researchers report in an article published in the Journal of Alzheimer´s Disease that 46% of patients who are diagnosed with Alzheimer´s disease in Sweden live alone in their homes, in particular older women.
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.
› Verified 2 days ago
| Provider Name | Marissa Fortuna |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891402830 PECOS PAC ID: 8628435559 Enrollment ID: I20230607001949 |
News Archive
The study shows that L. reuteri Prodentis acts synergistically with standard treatment (scaling and root plaining, SRP) to significantly reduce probing pocket depth (PPD) and clinical attachment level (CAL) which are the two most important parameters to assess the severity of periodontitis. Furthermore L. reuteri Prodentis reveals - as the first probiotic ever - significant reductions of three different pathogens in patients with chronic periodontitis.
The smell of cut grass, freshly baked bread, childhood memories, lost loved ones. What happens when it's all gone?
A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found.
Swedish researchers report in an article published in the Journal of Alzheimer´s Disease that 46% of patients who are diagnosed with Alzheimer´s disease in Sweden live alone in their homes, in particular older women.
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.
› Verified 2 days ago
News Archive
The study shows that L. reuteri Prodentis acts synergistically with standard treatment (scaling and root plaining, SRP) to significantly reduce probing pocket depth (PPD) and clinical attachment level (CAL) which are the two most important parameters to assess the severity of periodontitis. Furthermore L. reuteri Prodentis reveals - as the first probiotic ever - significant reductions of three different pathogens in patients with chronic periodontitis.
The smell of cut grass, freshly baked bread, childhood memories, lost loved ones. What happens when it's all gone?
A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found.
Swedish researchers report in an article published in the Journal of Alzheimer´s Disease that 46% of patients who are diagnosed with Alzheimer´s disease in Sweden live alone in their homes, in particular older women.
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.
› Verified 2 days ago
Millennium Therapy Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5260 Northwest Blvd, Suite 2, Davenport, IA 52806 Phone: 563-445-2400 Fax: 563-445-2404 | |
Renee D Lass Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4626 Progress Dr Ste B, Davenport, IA 52807 Phone: 563-359-3736 Fax: 563-359-0153 | |
Quad Cities Internal Medicine Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3509 Spring St, Suite 3, Davenport, IA 52807 Phone: 563-359-5011 Fax: 359-355-3438 | |
Community Health Care, Inc. Outreach Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 902 W 4th St, Davenport, IA 52802 Phone: 563-336-3000 Fax: 563-336-3125 | |
Genesis Health Group Davenport Clinic Health Home Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1820 W 3rd St, Davenport, IA 52802 Phone: 563-421-0500 Fax: 563-326-1901 | |
Quad Cities Pediatrics, P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5510 Utica Ridge Rd Ste 100, Davenport, IA 52807 Phone: 563-424-2025 Fax: 563-424-2042 | |
Genesis Convenient Care Davenport Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1520 W 53rd St, Davenport, IA 52806 Phone: 563-421-3800 Fax: 563-421-3810 |